全文获取类型
收费全文 | 756篇 |
免费 | 4篇 |
国内免费 | 17篇 |
专业分类
安全科学 | 12篇 |
环保管理 | 17篇 |
综合类 | 676篇 |
基础理论 | 30篇 |
环境理论 | 2篇 |
污染及防治 | 17篇 |
评价与监测 | 6篇 |
社会与环境 | 10篇 |
灾害及防治 | 7篇 |
出版年
2023年 | 2篇 |
2022年 | 2篇 |
2021年 | 7篇 |
2020年 | 8篇 |
2018年 | 3篇 |
2017年 | 4篇 |
2016年 | 5篇 |
2015年 | 2篇 |
2014年 | 4篇 |
2013年 | 19篇 |
2012年 | 20篇 |
2011年 | 80篇 |
2010年 | 69篇 |
2009年 | 53篇 |
2008年 | 53篇 |
2007年 | 59篇 |
2006年 | 52篇 |
2005年 | 53篇 |
2004年 | 50篇 |
2003年 | 52篇 |
2002年 | 46篇 |
2001年 | 30篇 |
1999年 | 2篇 |
1997年 | 1篇 |
1996年 | 2篇 |
1995年 | 36篇 |
1994年 | 29篇 |
1993年 | 3篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1990年 | 4篇 |
1989年 | 3篇 |
1988年 | 4篇 |
1987年 | 1篇 |
1986年 | 3篇 |
1985年 | 1篇 |
1984年 | 6篇 |
1983年 | 4篇 |
1982年 | 1篇 |
1979年 | 1篇 |
排序方式: 共有777条查询结果,搜索用时 31 毫秒
571.
572.
Leonardo Gucciardo Anne Uyttebroek Ivo De Wever Marleen Renard Filip Claus Roland Devlieger Liesbeth Lewi Luc De Catte Jan Deprest 《黑龙江环境通报》2011,31(7):678-688
Sacrococcygeal teratoma (SCT) is one of the most common tumors in newborns with a birth prevalence of up to 1 in 21 700 births. Routine fetal anomaly screening programs allow for prenatal diagnosis in many cases. Fetal ultrasound with Doppler evaluation and more recently magnetic resonance imaging may be used to document the extent of the tumor as well as identifying the population at risk for serious fetal complications. Rapidly growing SCT and highly vascularized tumors are more likely to have hemodynamic repercussions. Fetal hydrops is usually considered as a poor prognostic marker and a potential indicator for fetal intervention. Newborns with SCT require stabilization prior to early surgical resection. In case of malignancy additional chemotherapy may be required. SCT may result in significant morbidity, either directly or as a consequence of surgical therapy. Careful postnatal follow-up is required for timely identification and treatment of complications as well as recurrence. This paper aims to review the perinatal management of this condition. Copyright © 2011 John Wiley & Sons, Ltd. 相似文献
573.
Prenatal gene therapy aims to deliver genes to cells and tissues early in prenatal life, allowing correction of a genetic defect, before long-term tissue damage has occurred. In contrast to postnatal gene therapy, prenatal application can target genes to a large population of dividing stem cells, and the smaller fetal size allows a higher vector-to-target cell ratio to be achieved. Early-gestation delivery may allow the development of immune tolerance to the transgenic protein which would facilitate postnatal repeat vector administration if needed. Targeting particular organs will depend on manipulating the vector to achieve selective tropism and on choosing the most appropriate gestational age and injection method for fetal delivery. Intra-amniotic injection reaches the skin, and other organs that are bathed in the fluid however since gene transfer to the lung and gut is usually poor more direct injection methods will be needed. Delivery to the liver and blood can be achieved by systemic delivery via the umbilical vein or peritoneal cavity. Gene transfer to the central nervous system in the fetus is difficult but newer vectors are available that transduce neuronal tissue even after systemic delivery. Copyright © 2011 John Wiley & Sons, Ltd. 相似文献
574.
575.
576.
577.
578.
579.
580.